Boston Scientific Wins FDA Approval of Stent for Smaller Blood Vessels

Xconomy Boston — 

Boston Scientific said today it has won clearance from the FDA to market the Taxus Express2 Atom Stent System. The new device, which props open clogged heart arteries, emits a small dose of a chemotherapy drug designed to minimize scarring around the implant. It is the only device approved for vessels as small as 2.25 millimeters in diameter, the Natick, MA-based company (NYSE: BSX) said in a statement. The company plans to start selling the device immediately.